Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul Angaran

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The Canadian Journal of Cardiology|August 3, 2013
Antiarrhythmic drugs in atrial fibrillation: do they have a future?Paul Angaran, Paul Dorian
The Canadian Journal of Cardiology|July 15, 2023
Beta-Blockers and Digoxin in Atrial Fibrillation: Back to the FuturePaul Dorian, Paul Angaran
The New England Journal of Medicine|July 21, 2021
Atrial FibrillationPaul Dorian, Paul Angaran
Heart Rhythm|May 29, 2016
Trials and tribulations: Antiarrhythmic drugs for the acute conversion of atrial fibrillationPaul Dorian, Paul Angaran
JACC. Clinical Electrophysiology|May 16, 2018
Symptoms and Quality of Life After Atrial Fibrillation Ablation: Two Different ConceptsPaul Dorian, Paul Angaran
The Canadian Journal of Cardiology|February 18, 2014
β-Blockers and atrial fibrillation: hypertension and other medical conditions influencing their usePaul Dorian, Paul Angaran
Heart (British Cardiac Society)|January 16, 2015
Palpitations and dizziness in a 64-year-old man: reassure and send him homeYasbanoo Moayedi, Ramanan Kumareswaran, Paul Angaran
Indian Pacing and Electrophysiology Journal|November 8, 2017
Non-arrhythmic pre-excitation-induced cardiomyopathyMehrdad Golian, Paul Angaran, Iqwal Mangat
The Canadian Journal of Cardiology|October 3, 2024
Atrial Fibrillation Ablation and Patient-Reported Outcomes: Principles for the AgesJonah Himelfarb, Paul Angaran, Paul Dorian
Indian Pacing and Electrophysiology Journal|December 29, 2025
Ventricular Tachycardia Termination in a 70-Year-Old Female with Arrhythmogenic Right Ventricular CardiomyopathyTadhg Prendiville, Paul Angaran, Iqwal Mangat
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The Canadian Journal of Cardiology|August 3, 2013
Antiarrhythmic drugs in atrial fibrillation: do they have a future?Paul Angaran, Paul Dorian
The Canadian Journal of Cardiology|July 15, 2023
Beta-Blockers and Digoxin in Atrial Fibrillation: Back to the FuturePaul Dorian, Paul Angaran
The New England Journal of Medicine|July 21, 2021
Atrial FibrillationPaul Dorian, Paul Angaran
Heart Rhythm|May 29, 2016
Trials and tribulations: Antiarrhythmic drugs for the acute conversion of atrial fibrillationPaul Dorian, Paul Angaran
JACC. Clinical Electrophysiology|May 16, 2018
Symptoms and Quality of Life After Atrial Fibrillation Ablation: Two Different ConceptsPaul Dorian, Paul Angaran
The Canadian Journal of Cardiology|February 18, 2014
β-Blockers and atrial fibrillation: hypertension and other medical conditions influencing their usePaul Dorian, Paul Angaran
Heart (British Cardiac Society)|January 16, 2015
Palpitations and dizziness in a 64-year-old man: reassure and send him homeYasbanoo Moayedi, Ramanan Kumareswaran, Paul Angaran
Indian Pacing and Electrophysiology Journal|November 8, 2017
Non-arrhythmic pre-excitation-induced cardiomyopathyMehrdad Golian, Paul Angaran, Iqwal Mangat
The Canadian Journal of Cardiology|October 3, 2024
Atrial Fibrillation Ablation and Patient-Reported Outcomes: Principles for the AgesJonah Himelfarb, Paul Angaran, Paul Dorian
Indian Pacing and Electrophysiology Journal|December 29, 2025
Ventricular Tachycardia Termination in a 70-Year-Old Female with Arrhythmogenic Right Ventricular CardiomyopathyTadhg Prendiville, Paul Angaran, Iqwal Mangat
Pageof 8